No evidence of SARS-CoV-2 reverse transcription and integration as the origin of chimeric transcripts in patient tissues.

Parry, Rhys; Gifford, Robert J; Lytras, Spyros; Ray, Stuart C; Coin, Lachlan J M

Parry, Rhys; Gifford, Robert J; Lytras, Spyros; Ray, Stuart C; Coin, Lachlan J M.

Afiliação

Parry R; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, QLD 4072, Australia; r.parry@uq.edu.au lachlan.coin@unimelb.edu.au.
Gifford RJ; Medical Research Council-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, United Kingdom.
Lytras S; Medical Research Council-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, United Kingdom.
Ray SC; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205.
Coin LJM; Department of Microbiology and Immunology, University of Melbourne at The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC 3000, Australia; r.parry@uq.edu.au lachlan.coin@unimelb.edu.au.

Proc Natl Acad Sci U S A ; 118(33)2021 08 17.

Article em En | MEDLINE | ID: mdl-34344759

Assuntos

COVID-19; SARS-CoV-2; Humanos; RNA Viral/genética; Transcrição Reversa; Replicação Viral

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google